Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nutex Health Inc.NUTX · Entity 4803 | Chief Medical Officer | March 09, 2026 | March 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nutex Health Inc.
Report date March 09, 2026 · Filed March 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee note (3) | 82,356 |
Last balance in matching sequence
After 2026-03-10 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-03-10 · Exercise / conversion · Acquired 2,084 · Balance 83,125 F1: Restricted stock units convert into common stock on a one-for-one basis. F3: Michael Chang PLLC ("CHANG") is the direct beneficial owner of 82,356 shares of Common Stock. Dr. Chang as the 100% owner and sole manager of CHANG, is an indirect beneficial owner of such shares. Dr. Chang is the direct owner of 984 shares. Row 2 · 2026-03-10 · Tax withholding · Disposed 769 · Balance 82,356 F2: Of the 2,084 shares issued subsequent to vesting, 769 shares were sold to cover tax withholding obligations. F3: Michael Chang PLLC ("CHANG") is the direct beneficial owner of 82,356 shares of Common Stock. Dr. Chang as the 100% owner and sole manager of CHANG, is an indirect beneficial owner of such shares. Dr. Chang is the direct owner of 984 shares. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2029-03-01 | Direct | 5,621 |
Reported balance
After 2026-03-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-03-10 · Exercise / conversion · Acquired 1,936 · Balance 5,621 F1: Restricted stock units convert into common stock on a one-for-one basis. F4: On March 10, 2026, the Reporting Person was granted 1,936 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: Of the 2,084 shares issued subsequent to vesting, 769 shares were sold to cover tax withholding obligations.
F3: Michael Chang PLLC ("CHANG") is the direct beneficial owner of 82,356 shares of Common Stock. Dr. Chang as the 100% owner and sole manager of CHANG, is an indirect beneficial owner of such shares. Dr. Chang is the direct owner of 984 shares.
F4: On March 10, 2026, the Reporting Person was granted 1,936 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 10, 2026 Filed Mar 11, 2026 21:36 UTC | Nutex Health Inc. NUTX · Entity 4803 | Exercise / conversionRestricted Stock Units · Derivative | 1,936 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001919832-26-000001 · primary_doc.xml · derivative · entry 3 Chang Michael L. · CIK 0001919832 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,621 Underlying: Common Stock · 1,936 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · shares: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 10, 2026, the Reporting Person was granted 1,936 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029. F4 · derivative.expiration_date: On March 10, 2026, the Reporting Person was granted 1,936 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029. Read SEC document |
| March 10, 2026 Filed Mar 11, 2026 21:36 UTC | Nutex Health Inc. NUTX · Entity 4803 | Tax withholdingCommon Stock | 769 | $86.22 | $66,305.03 |
DisclosureSEC source: 0001919832-26-000001 · primary_doc.xml · nonDerivative · entry 2 Chang Michael L. · CIK 0001919832 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See note (3) Disclosed balance after: 82,356 F2 · shares: Of the 2,084 shares issued subsequent to vesting, 769 shares were sold to cover tax withholding obligations. F3 · ownership.nature: Michael Chang PLLC ("CHANG") is the direct beneficial owner of 82,356 shares of Common Stock. Dr. Chang as the 100% owner and sole manager of CHANG, is an indirect beneficial owner of such shares. Dr. Chang is the direct owner of 984 shares. Read SEC document |
| March 10, 2026 Filed Mar 11, 2026 21:36 UTC | Nutex Health Inc. NUTX · Entity 4803 | Exercise / conversionCommon Stock | 2,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001919832-26-000001 · primary_doc.xml · nonDerivative · entry 1 Chang Michael L. · CIK 0001919832 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See note (3) Disclosed balance after: 83,125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. F3 · ownership.nature: Michael Chang PLLC ("CHANG") is the direct beneficial owner of 82,356 shares of Common Stock. Dr. Chang as the 100% owner and sole manager of CHANG, is an indirect beneficial owner of such shares. Dr. Chang is the direct owner of 984 shares. Read SEC document |
| April 04, 2025 Filed Apr 14, 2025 19:35 UTC | Nutex Health Inc. NUTX · Entity 4803 | Tax withholdingCommon Stock | 266 | $72.10 | $19,177.86 |
DisclosureSEC source: 0001486189-25-000013 · primary_doc.xml · nonDerivative · entry 2 Chang Michael L. · CIK 0001919832 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See note (3) Disclosed balance after: 81,041 F2 · shares: Of the 1,250 shares issued subsequent to vesting, 266 shares were sold to cover tax withholding obligations. F3 · ownership.direct: Michael Chang PLLC ("CHANG") is the direct beneficial owner of 80,057 shares of Common Stock. Dr. Chang as the 100% owner and sole manager of CHANG, is an indirect beneficial owner of such shares. Dr. Chang is the direct owner of 984 shares. Read SEC document |
| March 10, 2025 Filed Apr 14, 2025 19:35 UTC | Nutex Health Inc. NUTX · Entity 4803 | Exercise / conversionRestricted Stock Units · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001486189-25-000013 · primary_doc.xml · derivative · entry 3 Chang Michael L. · CIK 0001919832 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 2,500 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · shares: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 10, 2025, the Reporting Person was granted 2,500 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028. F4 · derivative.expiration_date: On March 10, 2025, the Reporting Person was granted 2,500 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028. Read SEC document |
| March 01, 2025 Filed Apr 14, 2025 19:35 UTC | Nutex Health Inc. NUTX · Entity 4803 | Exercise / conversionCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001486189-25-000013 · primary_doc.xml · nonDerivative · entry 1 Chang Michael L. · CIK 0001919832 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See note (3) Disclosed balance after: 81,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. F3 · ownership.direct: Michael Chang PLLC ("CHANG") is the direct beneficial owner of 80,057 shares of Common Stock. Dr. Chang as the 100% owner and sole manager of CHANG, is an indirect beneficial owner of such shares. Dr. Chang is the direct owner of 984 shares. Read SEC document |
| June 28, 2024 Filed Jun 28, 2024 15:59 UTC | Nutex Health Inc. NUTX · Entity 4803 | GrantRestricted Stock Unit · Derivative | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001486189-24-000034 · primary_doc.xml · derivative · entry 1 Chang Michael L. · CIK 0001919832 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting F2 · derivative.exercise_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Dr. Chang, dated June 28, 2024, the 37,500 RSUs granted to Dr. Change will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027. F2 · derivative.expiration_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Dr. Chang, dated June 28, 2024, the 37,500 RSUs granted to Dr. Change will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027. F1 · derivative.underlying_shares: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 19:46 UTC | Nutex Health Inc. NUTX · Entity 4803 | GrantCommon Stock | 12,008,523 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-009699 · form4.xml · nonDerivative · entry 1 Chang Michael L. · CIK 0001919832 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Michael Chang PLLC Disclosed balance after: 12,008,523 F1 · price: At the closing of the business combination pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on February 14, 2022, as supplemented, the reporting person received 3.571428575 shares of Common Stock of the Issuer in exchange for each membership interest in Nutex Health Holdco LLC. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.